NCT04650191View on ClinicalTrials.gov

Surfactant Protein Genetic Variants in COVID-19 Infection

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Coronavirus Infection
Interventions
OTHER

Identification of genetic variants

DNA will be extracted from whole blood from study subjects

Trial Locations (1)

17033

Milton S. Hershey Medical center, Hershey

All Listed Sponsors
lead

Milton S. Hershey Medical Center

OTHER

NCT04650191 - Surfactant Protein Genetic Variants in COVID-19 Infection | Biotech Hunter | Biotech Hunter